Author Archives: JAIDS

Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of…

No abstract available

Posted in Journal Watch | Leave a comment

Clinical Versus Rapid Molecular HIV Diagnosis in Hospitalized African Infants: A Randomized…

Objective: Many African infants fail to receive their diagnostic HIV molecular test results and subsequently, antiretroviral therapy (ART).

Posted in Journal Watch | Leave a comment

The Impact of a Food Assistance Program on Nutritional Status, Disease Progression, and Food…

Background: Although the last decade has seen increased access to antiretroviral therapy across the developing world, widespread food insecurity and undernutrition continue to compromise an effective response to the AIDS epidemic.

Posted in Journal Watch | Leave a comment

Qualitative Assessment of the Integration of HIV Services With Infant Routine Immunization…

Background: In 2009, a project was implemented in 8 primary health clinics throughout Tanzania to explore the feasibility of integrating pediatric HIV prevention services with routine infant immunization visits.

Posted in Journal Watch | Leave a comment

Predictors of First Follow-up HIV Testing for Couples’ Voluntary HIV Counseling and Testing in…

Introduction: We describe predictors of first follow-up testing for concordant negative and discordant couples seeking joint voluntary HIV counseling and testing in Ndola, Zambia, where cohabiting couples account for an estimated two-thirds of incident HIV infections.

Posted in Journal Watch | Leave a comment

Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients…

Background: Despite widespread use in HIV and hepatitis B virus (HBV) infection, the effectiveness of tenofovir (TDF) has not been studied extensively outside of small cohorts of coinfected patients with HBV-HIV.

Posted in Journal Watch | Leave a comment

Transmitted Drug Resistance and Antiretroviral Treatment Outcomes in Non-Subtype B…

Background: We compared treatment outcomes of transmitted drug resistance (TDR) in patients on fully or partially sensitive drug regimens.

Posted in Journal Watch | Leave a comment

Antiviral Activity of Genital Tract Secretions After Oral or Topical Tenofovir Pre-exposure…

Background: Surrogate markers of HIV-1 pre-exposure prophylaxis and microbicide efficacy are needed.

Posted in Journal Watch | Leave a comment

Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral…

Background: Recent studies suggest higher cumulative HIV viremia exposure measured as viremia copy-years (VCY) is associated with increased all-cause mortality.

Posted in Journal Watch | Leave a comment

Latent Tuberculosis Screening Using Interferon-Gamma Release Assays in an Australian…

Background: There are limited data from high-income countries on the performance of interferon-gamma release assays in screening for latent tuberculosis infection (LTBI).

Posted in Journal Watch | Leave a comment

Socioeconomic Determinants of Mortality in HIV: Evidence From a Clinical Cohort in Uganda

Objective: To delineate the association between baseline socioeconomic status (SES) indicators and mortality and lost to follow-up (LTFU) in a cohort of HIV-infected individuals enrolled in antiretroviral therapy (ART) in urban Uganda.

Posted in Journal Watch | Leave a comment

Predictive Value of Anemia for Tuberculosis in HIV-Infected Patients in Sub-Saharan Africa: An…

Background: The relationship between anemia and undiagnosed tuberculosis (TB) in patients living with HIV in sub-Saharan Africa is incompletely defined.

Posted in Journal Watch | Leave a comment

Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS

Objectives: Cytomegalovirus (CMV)-specific T-cell effectors (CMV-Teff) protect against CMV end-organ disease (EOD).

Posted in Journal Watch | Leave a comment

Immune Activation Is Associated With Increased Gut Microbial Translocation in Treatment-Naive,…

Background: Gut damage resulting in microbial translocation (MT) is considered a major cause of immune activation (IA) in HIV infection, but data in children are limited, particularly in the absence of antiretroviral therapy.

Posted in Journal Watch | Leave a comment